ES2583004T3 - Olleya marilimosa y su uso en un método para la preparación de una composición que contiene zeaxantina - Google Patents

Olleya marilimosa y su uso en un método para la preparación de una composición que contiene zeaxantina Download PDF

Info

Publication number
ES2583004T3
ES2583004T3 ES10187448.5T ES10187448T ES2583004T3 ES 2583004 T3 ES2583004 T3 ES 2583004T3 ES 10187448 T ES10187448 T ES 10187448T ES 2583004 T3 ES2583004 T3 ES 2583004T3
Authority
ES
Spain
Prior art keywords
preparation
composition containing
containing zeaxanthin
marilimosa
olleya
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10187448.5T
Other languages
English (en)
Inventor
Ken-Shwo Dai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vigenent Inc
Original Assignee
Vigenent Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vigenent Inc filed Critical Vigenent Inc
Application granted granted Critical
Publication of ES2583004T3 publication Critical patent/ES2583004T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P23/00—Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Abstract

Una cepa de bacteria aislada de Olleya marilimosa con Número de acceso de Depósito CCTCC M2010201 para la producción de zeaxantina.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10

Claims (1)

  1. imagen1
ES10187448.5T 2010-10-13 2010-10-13 Olleya marilimosa y su uso en un método para la preparación de una composición que contiene zeaxantina Active ES2583004T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10187448.5A EP2441433B1 (en) 2010-10-13 2010-10-13 Olleya marilimosa and its use in a method for the preparation of a composition comprising zeaxanthin

Publications (1)

Publication Number Publication Date
ES2583004T3 true ES2583004T3 (es) 2016-09-16

Family

ID=43706875

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10187448.5T Active ES2583004T3 (es) 2010-10-13 2010-10-13 Olleya marilimosa y su uso en un método para la preparación de una composición que contiene zeaxantina

Country Status (3)

Country Link
EP (1) EP2441433B1 (es)
ES (1) ES2583004T3 (es)
PL (1) PL2441433T3 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017173241A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
JP2019510037A (ja) 2016-03-31 2019-04-11 ゴジョ・インダストリーズ・インコーポレイテッド 抗菌ペプチド刺激性洗浄組成物
CA3043748A1 (en) 2016-11-23 2018-05-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3891504A (en) 1970-07-31 1975-06-24 Hoffmann La Roche Process for the manufacture of zeaxanthin
BE790289A (fr) * 1971-10-27 1973-02-15 Nestle Sa Procede de fabrication de zeaxanthine
CH572981A5 (es) 1973-07-26 1976-02-27 Nestle Sa
CH572980A5 (es) 1973-07-26 1976-02-27 Nestle Sa
DK171297B1 (da) 1987-03-27 1996-08-26 Hoffmann La Roche Fremgangsmåde til fremstilling af cyclohexenderivater som mellemprodukter til fremstilling af zeaxanthin samt cyclohexenderivater
US5227507A (en) 1987-03-27 1993-07-13 Hoffmann-La Roche Inc. Ethynylcyclohexene compounds and processes for manufacture thereof
ES2104608T3 (es) 1989-08-30 1997-10-16 Applied Food Biotech Inc Procedimiento para la produccion de una composicion que contiene zeaxantina utilizando un microorganismo de la especie flavobacterium multivorum.
US5648564A (en) 1995-12-21 1997-07-15 Kemin Industries, Inc. Process for the formation, isolation and purification of comestible xanthophyll crystals from plants
WO1999018814A1 (en) * 1997-10-14 1999-04-22 Quest International B.V. Preparation for the enhancement of the antioxidant status of cells
US6191293B1 (en) 1998-04-20 2001-02-20 Inexa, Industria Extractora C.A. Trans-xanthophyll ester concentrates of enhanced purity and methods of making same
US7691406B2 (en) * 2000-10-27 2010-04-06 ZeaVision LLC. Zeaxanthin formulations for human ingestion
US6784351B2 (en) 2001-06-29 2004-08-31 Ball Horticultural Company Targetes erecta marigolds with altered carotenoid compositions and ratios
IL146449A0 (en) * 2001-11-12 2002-07-25 Lycored Natural Prod Ind Ltd Method and pharmaceutical preparations for reducing the activity of cells
WO2003048284A1 (en) 2001-11-29 2003-06-12 University Of Maryland Process for extraction and purification of lutein, zeaxanthin and rare carotenoids from marigold flowers and plants
US8088363B2 (en) * 2002-10-28 2012-01-03 Zeavision Llc Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
PE20050398A1 (es) 2003-09-22 2005-06-03 Rosales Jose Antonio Socla Proceso y purificacion de las xantofilas de marigold
GB0509341D0 (en) * 2005-05-07 2005-06-15 Aquapharm Bio Discovery Ltd Biological prodution of Zeaxanthin
CA2625433A1 (en) * 2005-10-11 2007-04-19 Lycored Ltd. Carotenoid oxidation products as chemopreventive and chemotherapeutic agents
WO2007067957A1 (en) * 2005-12-07 2007-06-14 Cardax Pharmaceuticals, Inc. Structural carotenoid analogs or derivatives for the modulation of systemic and/or target organ redox status
US8716533B2 (en) * 2009-05-29 2014-05-06 Kalamazoo Holdings, Inc. Methods of saponifying xanthophyll esters and isolating xanthophylls

Also Published As

Publication number Publication date
EP2441433B1 (en) 2016-04-20
PL2441433T3 (pl) 2016-10-31
EP2441433A1 (en) 2012-04-18

Similar Documents

Publication Publication Date Title
ES2582284T3 (es) Composición que comprende microbiota intestinal humana anaeróbicamente cultivada
ES2502472T3 (es) Composición adhesiva para su uso en un inmunosensor
ES2561253T3 (es) Bacterias probióticas que tienen actividad antioxidante y uso de las mismas
ES2524551T3 (es) Composición de gel
ES2496092T3 (es) El uso de amisulprida para tratar náuseas y vómitos posoperatorios
ES2661582T3 (es) Efecto antiinflamatorio de la celulosa microfibrilada
BR112014010433A2 (pt) método e máquina para produzir uma cápsula de uso único para bebidas e cápsula obtida com o método
CL2013003146A1 (es) Formulación estable que comprende anticuerpo anti alfa 4 beta 7 y al menos un aminoacido libre; metodo para preparar la formulación; uso para tratar enfermedad inflamatoria.
CL2012003625A1 (es) Una composicion acuosa que contiene bromhexina, en donde la composicion tiene una cantidad de azucar-alcoholes inferior a 10 g referida a 100 ml de la composicion; y su uso para la terapia secretorica en enfermedades broncopulmonares agudas y cronicas.
ES2574417T3 (es) Composición de gel
CL2012002328A1 (es) Anticuerpo aislado anti-tat419 que inhibe la proliferación celular; ácido nucleico que lo codifica; célula que lo produce; método para identificar anticuerpos que unen un epítopo antigénico tat419; método para inhibir la proliferación de una célula que expresa un péptido tat419; y su uso en el tratamiento de tumores cancerígenos.
CL2014000840A1 (es) Metodo para la produccion simultanea de etanol y un producto solido fermentado; etanol; producto solido y su uso; alimento.
CR20140168A (es) Bandeja de apilamiento
ES2613400T3 (es) Método para mejorar la fagocitosis de células que exponen fosfatidilserina
SG10201906304TA (en) Use of perfusion decellularized liver for islet cell recellularization
ES2620754T3 (es) Uso de 5-androstano (alquil)-3,5,6-triol en la preparación de fármacos neuroprotectores
UY34406A (es) Compuestos y métodos para mejorar la respuesta inmune innata
BR112013001423A2 (pt) método, método in vitro, uso e kit útil para realizar o método
ES2508165T3 (es) Lactoferrina y sustancia blanca
AR088394A1 (es) Metodo para producir productos de combustible nuclear con una carga elevada de leu y el producto de combustible nuclear correspondiente
ES2616017T3 (es) Composiciones que contienen sulfato de condroitina, nattocinasa y compuestos de sulfhidrilo para su uso en el tratamiento de inflamación
ES2634034T3 (es) Composiciones nutricionales con copos de fruta que contienen ácido docosahexenoico
ES2583004T3 (es) Olleya marilimosa y su uso en un método para la preparación de una composición que contiene zeaxantina
CL2012003265A1 (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de enfermedades infecciosas; composicion farmacéutica y/o dermocosmética antiinflamatoria que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo.
ES2660019T3 (es) Parche que contiene diclofenaco y tiocolchicósido